Soren Boesgaard
Overview
Explore the profile of Soren Boesgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larsson J, Kristensen S, Deis T, Warming P, Schou M, Kober L, et al.
ESC Heart Fail
. 2024 Sep;
12(1):477-486.
PMID: 39344872
Aims: Socioeconomic deprivation is a risk marker for worse prognosis in patients with heart failure (HF), and a potential barrier to referral for advanced HF evaluation. The relationship between socioeconomic...
2.
Moller J, Engstrom T, Jensen L, Eiskjaer H, Mangner N, Polzin A, et al.
N Engl J Med
. 2024 Apr;
390(15):1382-1393.
PMID: 38587239
Background: The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock remains unclear. Methods:...
3.
Zohori Bahrami H, Hasselbalch R, Soholm H, Thomsen J, Sorgaard M, Kofoed K, et al.
J Cardiovasc Pharmacol
. 2024 Mar;
83(5):466-473.
PMID: 38452283
Diastolic dysfunction (DD) in heart failure is associated with increased myocardial cytosolic calcium and calcium-efflux through the sodium-calcium exchanger depends on the sodium gradient. Beta-3-adrenoceptor (β3-AR) agonists lower cytosolic sodium...
4.
Grand J, Moller J, Hassager C, Schmidt H, Molstrom S, Boesgaard S, et al.
Resuscitation
. 2023 Dec;
194:110094.
PMID: 38103857
Objectives: The aim was to investigate the advanced hemodynamic effects of the two MAP-targets during intensive care on systemic hemodynamics in comatose patients after cardiac arrest. Design: Secondary analysis of...
5.
Hassager C, Schmidt H, Moller J, Grand J, Molstrom S, Beske R, et al.
N Engl J Med
. 2022 Nov;
388(10):888-897.
PMID: 36342119
Background: Guidelines recommend active fever prevention for 72 hours after cardiac arrest. Data from randomized clinical trials of this intervention have been lacking. Methods: We randomly assigned comatose patients who...
6.
Schmidt H, Kjaergaard J, Hassager C, Molstrom S, Grand J, Borregaard B, et al.
N Engl J Med
. 2022 Aug;
387(16):1467-1476.
PMID: 36027567
Background: The appropriate oxygenation target for mechanical ventilation in comatose survivors of out-of-hospital cardiac arrest is unknown. Methods: In this randomized trial with a 2-by-2 factorial design, we randomly assigned...
7.
Kjaergaard J, Moller J, Schmidt H, Grand J, Molstrom S, Borregaard B, et al.
N Engl J Med
. 2022 Aug;
387(16):1456-1466.
PMID: 36027564
Background: Evidence to support the choice of blood-pressure targets for the treatment of comatose survivors of out-of-hospital cardiac arrest who are receiving intensive care is limited. Methods: In a double-blind,...
8.
Perez-Hernandez M, van Opbergen C, Bagwan N, Vissing C, Marron-Linares G, Zhang M, et al.
Circulation
. 2022 Aug;
146(11):851-867.
PMID: 35959657
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by high propensity to life-threatening arrhythmias and progressive loss of heart muscle. More than 40% of reported genetic variants linked to ARVC...
9.
Bundgaard H, Raja A, Iversen K, Valeur N, Tonder N, Schou M, et al.
Circ Heart Fail
. 2022 Jun;
15(7):e009120.
PMID: 35758031
Background: β3-AR (β3-adrenergic receptor) stimulation improved systolic function in a sheep model of systolic heart failure (heart failure with reduced ejection fraction [HFrEF]). Exploratory findings in patients with New York...
10.
Nelson L, Rossing K, Boesgaard S, Moller-Sorensen H, Moller C, Gustafsson F, et al.
Scand Cardiovasc J
. 2022 Apr;
56(1):65-72.
PMID: 35481404
. Heart transplantation (HTx) has become an established treatment option in patients with end-stage heart failure. The aim of this study was to report on long-term outcome over the past...